Kim Hyun, Suzuki Haruka, Matsuoka Masanori, Matsuba Takashi, Yokoyama Kazumasa, Nakajima Chie, Suzuki Yasuhiko
Department of Global Epidemiology, Hokkaido University Research Center for Zoonosis Control, Japan.
Nihon Hansenbyo Gakkai Zasshi. 2011 Feb;80(1):17-27. doi: 10.5025/hansen.80.17.
Drugs included in new-quinolone are used for the treatment of leprosy with single lesion. These drugs are also known to be effective drugs for the treatment of multi-drug resistant M. tuberculosis. Recent emergence of new-quinolone resistant M. leprae and M. tuberculosis enforced the urgent elucidation of the mode of emergence of new-quinolone resistant strains. In this review, new-quinolone drugs, their mode of action and mechanism of acquisition of resistance by M. leprae and M. tuberculosis were explained. And rapid differentiation methods for resistant bacilli were also introduced.
新型喹诺酮类药物可用于治疗单病灶麻风病。众所周知,这些药物也是治疗耐多药结核分枝杆菌的有效药物。最近出现的对新型喹诺酮耐药的麻风分枝杆菌和结核分枝杆菌,促使人们迫切需要阐明新型喹诺酮耐药菌株的出现方式。在这篇综述中,对新型喹诺酮类药物、其作用方式以及麻风分枝杆菌和结核分枝杆菌获得耐药性的机制进行了解释。同时还介绍了耐药杆菌的快速鉴别方法。